Skip to content

Antibody to Neisseria meningitidis Group A (IgG) by Immunoassay

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of antibodies your body produces in response to exposure to *Neisseria meningitidis* Group A bacteria. These antibodies help your immune system recognize and fight the infection.

Quick summary

["Helps assess immune response to meningococcal vaccination or past infection."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
75755-9
Short code
MSSA DNA Spec Ql NAA+probe
Synonyms
MSSA DNA Spec Ql NAA+probe
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you’ve received the meningococcal vaccine (such as MenACWY) or have been exposed to *N. meningitidis* Group A. It can also be part of monitoring for immune response in certain conditions, like complement deficiency or after vaccination.

What to Expect Before the Test

No special preparation is needed. A blood sample will be drawn from a vein, usually in your arm. The process is quick and typically painless. You may feel a slight pinch, but most people tolerate it well.

What the Test Results Mean

Results indicate the presence of IgG antibodies against *N. meningitidis* Group A. A positive result suggests your immune system has recognized the bacteria, while a negative result may mean no detectable antibodies were found, which could prompt further evaluation.

Common Reasons for Testing

This test is often used to confirm immunity after vaccination, evaluate immune function in high-risk individuals (e.g., those with asplenia or complement disorders), or investigate unexplained infections.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

High antibody levels post-vaccination or infection indicate a strong immune response, reducing risk of meningococcal disease. Low or absent levels may signal inadequate immunity, prompting booster doses or additional investigations (e.g., immune function testing).

Short name

Anti-Meningococcal A Antibody (IgG)

Frequently asked questions

How long does it take to get results?
Results are typically available within 1–3 business days, depending on lab processing times. Your healthcare provider will discuss findings with you during your follow-up visit.
What does a positive result mean?
A positive result means your body has produced antibodies against *N. meningitidis* Group A, suggesting immunity. However, antibody levels alone don’t guarantee lifelong protection—vaccination schedules and booster doses remain important.
Can I get this test at home?
No, this test requires a blood sample collected by a healthcare professional in a clinical setting. Home blood tests for antibodies are not standard for this specific analyte.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy